DexCom, Inc. (DXCM)
NASDAQ: DXCM · IEX Real-Time Price · USD
111.66
+0.96 (0.87%)
At close: Jul 19, 2024, 4:00 PM
111.64
-0.02 (-0.02%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
DexCom Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for DexCom stock have an average target of 139.47, with a low estimate of 100 and a high estimate of 165. The average target predicts an increase of 24.91% from the current stock price of 111.66.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 6 | 7 | 7 | 7 | 6 |
Buy | 7 | 6 | 6 | 6 | 6 | 6 |
Hold | 2 | 2 | 2 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 15 | 14 | 15 | 16 | 16 | 15 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stifel | Stifel | Strong Buy Maintains $145 → $132 | Strong Buy | Maintains | $145 → $132 | +18.22% | Jul 12, 2024 |
Redburn Atlantic | Redburn Atlantic | Hold Initiates $130 | Hold | Initiates | $130 | +16.42% | May 30, 2024 |
Raymond James | Raymond James | Strong Buy Maintains $151 → $160 | Strong Buy | Maintains | $151 → $160 | +43.29% | Apr 26, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $144 → $145 | Strong Buy | Maintains | $144 → $145 | +29.86% | Apr 26, 2024 |
UBS | UBS | Strong Buy Maintains $153 → $163 | Strong Buy | Maintains | $153 → $163 | +45.98% | Apr 10, 2024 |
Financial Forecast
Revenue This Year
4.42B
from 3.62B
Increased by 21.97%
Revenue Next Year
5.27B
from 4.42B
Increased by 19.19%
EPS This Year
1.83
from 1.30
Increased by 41.14%
EPS Next Year
2.31
from 1.83
Increased by 25.69%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 4.6B | 5.7B | 6.7B | 7.8B | 9.0B |
Avg | 4.4B | 5.3B | 6.2B | 7.1B | 8.1B |
Low | 4.2B | 4.9B | 5.5B | 6.1B | 6.8B |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 26.7% | 28.3% | 27.5% | 25.5% | 27.5% |
Avg | 22.0% | 19.2% | 17.5% | 14.0% | 14.4% |
Low | 15.9% | 10.3% | 4.8% | -0.8% | -2.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.98 | 2.70 | 3.39 | 3.62 | 4.28 |
Avg | 1.83 | 2.31 | 2.84 | 3.42 | 4.03 |
Low | 1.64 | 2.00 | 2.39 | 3.16 | 3.71 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 52.7% | 47.1% | 47.1% | 27.7% | 25.1% |
Avg | 41.1% | 25.7% | 23.0% | 20.7% | 17.6% |
Low | 26.2% | 9.1% | 3.7% | 11.2% | 8.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.